Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Völkl

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
MMW Fortschritte Der Medizin|March 20, 2026
[Recognizing, classifying, and treating thrombocytopenia]Michael Völkl, Karsten Spiekermann, Michael von Bergwelt-Baildon
BMC Cancer|April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcomaLuc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
BMC Cancer|March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatmentLuc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Oncology and Therapy|June 5, 2026
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort StudyMichael Hoberger, Dorit Di Gioia, Romy L Zuber, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysisMichael Hoberger, Romy L Zuber, Anton Burkhard-Meier, et al.
Cardio-Oncology (London, England)|June 26, 2025
Primary cardiac sarcoma: insights from two decades of multimodal management at LMU MunichAnton Burkhard-Meier, Dorit Di Gioia, Vindi Jurinovic, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
MMW Fortschritte Der Medizin|March 20, 2026
[Recognizing, classifying, and treating thrombocytopenia]Michael Völkl, Karsten Spiekermann, Michael von Bergwelt-Baildon
BMC Cancer|April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcomaLuc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Durable response to nivolumab in combination with regional hyperthermia in a patient with PD-L1-negative metastatic head and neck squamous cell carcinomaLuc M Berclaz, Anton Burkhard-Meier, Axel Lechner, et al.
BMC Cancer|March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatmentLuc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Journal of Cancer Research and Clinical Oncology|April 26, 2025
First-line pazopanib in patients with metastatic epithelioid hemangioendothelioma: a retrospective single-center analysisAnton Burkhard-Meier, Vera Valerie Rechenauer, Vindi Jurinovic, et al.
Oncology and Therapy|June 5, 2026
Machine Learning-Guided Survival Prediction and Treatment Sequencing in Advanced Soft Tissue Sarcoma Beyond Second-Line Therapy: A Retrospective Cohort StudyMichael Hoberger, Dorit Di Gioia, Romy L Zuber, et al.
Journal of Cancer Research and Clinical Oncology|January 8, 2026
Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysisMichael Hoberger, Romy L Zuber, Anton Burkhard-Meier, et al.
Cardio-Oncology (London, England)|June 26, 2025
Primary cardiac sarcoma: insights from two decades of multimodal management at LMU MunichAnton Burkhard-Meier, Dorit Di Gioia, Vindi Jurinovic, et al.
Pageof 1